Lymphocyte

Type: Product
Name: Lymphocyte
First reported 4 hours ago - Updated 4 hours ago - 1 reports

Bobbies swapping beat for saddle for charity cycle

A LEUKAEMIA sufferer has rounded up a team of cops to take part in a charity bike ride.PCSO Ray Aylott, ofThorpe le Soken is leading a 13 member group of friends, family and colleagues to raise money for Leukaemia Care by competing in the Tour de Tendring ... [Published Essex County Standard - 4 hours ago]
First reported 6 hours ago - Updated 6 hours ago - 1 reports

Supplemental New Drug Application for IMBRUVICA? ibrutinib Submitted to the U.S. FDA

By a News Reporter-Staff News Editor at Biotech Week Janssen Research & Development, LLC ("Janssen") announced the submission of a supplemental New Drug Application (sNDA) for IMBRUVICA? (ibrutinib) to the U.S. Food and Drug Administration (FDA) by its ... [Published Pharmacy Choice - 6 hours ago]
First reported 9 hours ago - Updated 9 hours ago - 1 reports

New method shows how cells ward off oral diseases

Researchers at Case Western Reserve University  have found a less invasive way to extract single rare immune cells from the mouth to study how the mouth’s natural defences ward off infection and inflammation.Puspa Pandiyan, assistant professor of biological ... [Published Healthcare Learning Company - 9 hours ago]
First reported 16 hours ago - Updated 16 hours ago - 1 reports

What makes some cancers more deadly

A Flinders University researcher is searching for answers as to why some leukaemia sufferers live a normal lifespan while others succumb to the disease within months .Dr Lauren Thurgood, based in the Department of Haematology and Genetic Pathology , is ... [Published In Daily - 16 hours ago]
First reported Apr 22 2014 - Updated Apr 22 2014 - 1 reports

Arzerra(r) (ofatumumab) approved for the treatment of Chronic Lymphocytic

Leukemia, Diplomat to distribute04/22 06:44 CDT Leukemia, Diplomat to distribute FLINT, Mich., April 22, 2014FLINT, Mich., April 22, 2014 /PRNewswire-iReach/ -- The US Food and Drug Administration has announced the expanded approval of Arzerra(r) (ofatumumab) ... [Published Finwin - Apr 22 2014]
First reported Apr 22 2014 - Updated Apr 22 2014 - 1 reports

STOCKS NEWS NORDICS-Denmark's Genmab soars after U.S. approval

Shares in Danish biotechGenmab surge on Tuesday after an expanded approval bythe United States Food and Drug Administration (FDA) for the useof the company's blood cancer drug Arzerra.. COPENHAGEN, April 22 The news was announced on April 17 while the ... [Published Reuters - Apr 22 2014]
First reported Apr 22 2014 - Updated Apr 22 2014 - 1 reports

Insulin‐like growth factor 1 receptor signaling induced by supraphysiological doses of IGF‐1 in human peripheral blood lymphocytes

Insulin‐like growth factor‐1 (IGF‐1) mediates some of growth hormone (GH) anabolic functions through its receptor, IGF1R. Following ligand binding, intracellular signaling pathways are activated favouring proliferation, cell survival, tissue growth, development ... [Published Bionity.com - Apr 22 2014]
First reported Apr 22 2014 - Updated Apr 22 2014 - 1 reports

X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes

X-linked adrenoleukodystrophy (X-ALD) is a fatal neurodegenerative disease caused by mutations in the ABCD1 gene, encoding a member of the peroxisomal ABC transporter family. The ABCD1 protein transports CoA-activated very long-chain fatty acids (VLCFAs) ... [Published Bionity.com - Apr 22 2014]
First reported Apr 22 2014 - Updated Apr 22 2014 - 1 reports

The Benefits Of Massage

Massage is great for you for a multitude of reasons. From relaxation to improving blood flow , easing muscle tension and even the feeling of a little ‘selfish’ indulgence, the benefits are many. So rid yourself of the guilt because massage shouldn’t just ... [Published Shesaid - Apr 22 2014]
First reported Apr 22 2014 - Updated Apr 22 2014 - 1 reports

CXCR4 Is Dispensable for T Cell Egress from Chronically Inflamed Skin via the Afferent Lymph

T cell recirculation through extralymphoid tissues is essential to immune surveillance, host defense and inflammation. In this process, T cells enter the tissue from the blood and subsequently leave via the afferent lymph. In the absence of inflammation, ... [Published PLoS medicine - Apr 22 2014]
First reported Apr 21 2014 - Updated Apr 21 2014 - 1 reports

Studies from Nanjing Medical University Describe New Findings in Cancer Vaccines

(NewsRx) -- By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- Researchers detail new data in Immunization. According to news reporting originating in Jiangsu, People's Republic of China, by NewsRx journalists, research stated, "Attenuated ... [Published NewsRX - Apr 21 2014]
First reported Apr 21 2014 - Updated Apr 21 2014 - 1 reports

Definiens Sponsors the World Wide Clinical Validation of the Immunoscore

Definiens, the global leader in image analysis for digital pathology and diagnostics, announced today that it has signed an agreement with INSERM Transfert to sponsor the worldwide consortium for the validation of the Immunoscore, a new approach to cancer ... [Published Advance for Administrators of the Laboratory - Apr 21 2014]

Quotes

"Also provided by the present disclosure is a method of inhibiting the activity of autoimmune, autologous, cytotoxic T and B cells in a patient suffering from relapsing-remitting MS, comprising: administering a therapeutically effective amount of autologous T reg cells to the patient. In some embodiments, the administering step is performed more than one time throughout the life of the patient. In certain embodiments, the administering step is performed every 1 to 7, 2 to 6, 3 to 6, or 4 to 5 months after the first administering step. In many embodiments, the administering step comprises administering about 1.times.10.sup.6 to about 1.1.times.10.sup.7 autologous T reg cells per kg body weight to the patient. In many embodiments, the autologous T reg cells are administered by subcutaneous, intravenous, and/or intramuscular injection. In some embodiments, the autologous T reg cells administered are expanded ex vivo before they are administered to the patient."
...on current treatment options and create better outcomes for patients," said Gary Gordon, M D , vice president, Oncology Development, AbbVie. "We have made substantial progress advancing our lead investigational compounds into Phase III testing and remain dedicated to the continued development of the other compounds in our oncology pipeline."

More Content

All (671) | News (571) | Reports (1) | Blogs (87) | Audio/Video (0) | Fact Sheets (0) | Press Releases (4)
sort by: Date | Relevance
Patent Issued for Treatment Method for Relapsin... [Published HispanicBusiness.com - 1 hour ago]
AbbVie to present data on investigational compo... [Published European Pharmaceutical Review - 1 hour ago]
Human medicines European public assessment repo... [Published European Medicines Agency - 2 hours ago]
Bobbies swapping beat for saddle for charity cycle [Published Essex County Standard - 4 hours ago]
AbbVie to Present Data on Investigational Compo... [Published TickerTech.com - 6 hours ago]
Disease-causing IgE antibodies are regulated to... [Published Medical Xpress - 6 hours ago]
Supplemental New Drug Application for IMBRUVICA... [Published Pharmacy Choice - 6 hours ago]
Vitamin E: Vital for health and performance [Published WorldPoultry.net - 8 hours ago]
New method shows how cells ward off oral diseases [Published Healthcare Learning Company - 9 hours ago]
Community-Based Network Study of Protein-Carboh... [Published PLoS medicine - 10 hours ago]
Clinic speak: highly-effective DMTs and immuniz... [Published Multiple Sclerosis Research - 11 hours ago]
Dorking cyclists plan city centre ride in memor... [Published Dorking and Leatherhead Advertiser - 12 hours ago]
Novartis deal may shift state research landscape [Published Columbus - 14 hours ago]
What makes some cancers more deadly [Published In Daily - 16 hours ago]
Tripartite Motif-Containing Protein 30 Modulate... [Published PLoS medicine - 20 hours ago]
LMKB/MARF1 Localizes to mRNA Processing Bodies,... [Published PLoS medicine - 20 hours ago]
Novartis deals could affect Bay State drug rese... [Published Boston Globe - 22 hours ago]
Solitary organizing pneumonia in systemic scler... [Published Arthritis & Rheumatism - 22 hours ago]
TxCell lists on Euronext Paris [Published NYSE Euronext - 23 hours ago]
GSK and Genmab obtain FDA clearance for Arzerra... [Published Pharmaceutical Technology - Apr 22 2014]
Data from Genzyme’s Multiple Sclerosis Franchis... [Published Nasdaq - Apr 22 2014]
Data from Genzyme's Multiple Sclerosis Franchis... [Published FinanzNachrichten.de - Apr 22 2014]
Arzerra(r) (ofatumumab) approved for the treatm... [Published Finwin - Apr 22 2014]
STOCKS NEWS NORDICS-Denmark's Genmab soars afte... [Published Reuters - Apr 22 2014]
Form: Non-technical summaries granted during 20... [Published Government UK - Apr 22 2014]
Form: Non-technical summaries granted during 20... [Published Government UK - Apr 22 2014]
Gold Nanoparticle Array Fabricated Onto Hybrid ... [Published Azonano - Apr 22 2014]
Insulin‐like growth factor 1 receptor signaling... [Published Bionity.com - Apr 22 2014]
X-linked adrenoleukodystrophy: very long-chain ... [Published Bionity.com - Apr 22 2014]
The Benefits Of Massage [Published Shesaid - Apr 22 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Clinic speak: highly-effective DMTs and immuniz... [Published Multiple Sclerosis Research - 11 hours ago]
Vaccinations on highly-effective DMTs; what you need to know. #ClinicSpeak #MSBlog #MSResearch "This study below shows that MSers treated with natalizumab mount an immune response to both a memory, or recall, vaccine (tetanus) and a new vaccine challenge ...
Gluten-free skin and beauty products: Extractin... [Published Science-Based Medicine - Apr 21 2014]
Even though yesterday was Easter, and, as unreligious as I am, I was still thinking of taking it easy, there was one target that popped up that I just couldn’t resist. My wife and I were sitting around yesterday reading the Sunday papers and perusing ...
GSK and Genmab receive FDA approval for Arzerra... [Published PR Newswire: Policy & Public Interest - Apr 17 2014]
LONDON, April 17, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE: GSK) and Genmab A/S (OMX: GEN) announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), ...
Exome sequencing in single cells from the cereb... [Published Multiple Sclerosis Journal RSS feed -- OnlineFi ... - Apr 16 2014]
Background: Genome-wide association studies (GWAS) have identified over 100 germline variants that influence susceptibility to multiple sclerosis, most of which map within or near to genes with immunological function. However, the role of somatic mutations ...
Opinion/decision on a Paediatric Investigation ... [Published Opinion/decision on a Paediatric Investigation ... - Apr 16 2014]
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Lion Biotechnologies' Lead Program With Nationa... [Published GlobeNewswire: Advertising News - Apr 07 2014]
Lion Biotechnologies to Present at the 4th Annu... [Published GlobeNewswire: Acquisitions News - Mar 24 2014]
Cytocell Ltd lance une nouvelle sonde d'hématol... [Published PR Newswire - Nov 26 2013]
Health Canada Approves Genzyme's AUBAGIO® (teri... [Published PR Newswire - Nov 20 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.